| 1511 |
National Cancer Institute |
Html |
en |
Small Cell Lung Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of small cell lung cancer. |
| clinical trial | 0.236127 |
| treatment | 0.276669 |
| patients | 0.200061 |
| Lung Cancer Prevention | 0.201183 |
| cancer cells | 0.289303 |
| body | 0.206914 |
| Lung Cancer Treatment | 0.223408 |
|
| PDQ cancer information | 0.202281 |
| cell lung cancer | 0.911961 |
| small cell lung | 0.946074 |
| radiation therapy | 0.266516 |
| National Cancer Institute | 0.212636 |
| clinical trials | 0.458637 |
| information | 0.20384 |
|
CLICK HERE |
| 1574 |
National Cancer Institute |
Html |
en |
Parathyroid Cancer Treatment (PDQ®)–Patient Version |
The parathyroid glands are four pea-sized organs found in the neck near the thyroid gland. Find out about risk and genetic factors, symptoms, tests to diagnose, prognosis, staging, and treatment for parathyroid cancer. |
| entire parathyroid gland | 0.322718 |
| body | 0.312231 |
| Parathyroid hormone test | 0.326008 |
| PDQ cancer information | 0.344395 |
| clinical trial search | 0.297288 |
| parathyroid cancer spreads | 0.351955 |
| cancer information summary | 0.316321 |
| clinical trial | 0.381391 |
| parathyroid hormone | 0.446163 |
| patients | 0.279411 |
| treatment clinical trial | 0.267117 |
| NCI PDQ cancer | 0.284168 |
| parathyroid cancer | 0.907418 |
| parathyroid gland | 0.458873 |
| lymph nodes | 0.287148 |
| supportive care | 0.306655 |
| radiation therapy | 0.415255 |
| Recurrent parathyroid cancer | 0.380003 |
| Treatment Editorial Board | 0.27063 |
| metastatic parathyroid cancer | 0.402384 |
| general cancer information | 0.273517 |
| treatment | 0.412907 |
| Parathyroid Cancer Home | 0.340383 |
| new cancer treatments | 0.272069 |
|
| benign parathyroid adenoma | 0.327035 |
| NCI-supported cancer | 0.273639 |
| cancer cells | 0.359072 |
| standard treatment | 0.270825 |
| parathyroid cancer look | 0.361006 |
| parathyroid adenoma | 0.339034 |
| Cancer Information Service | 0.274336 |
| treatment clinical trials | 0.292746 |
| National Cancer Institute | 0.358229 |
| Parathyroid Cancer Treatment | 0.357344 |
| new treatment | 0.296569 |
| calcium | 0.286368 |
| clinical trials | 0.583365 |
| radioactive substance | 0.27332 |
| Cancer Care page | 0.26586 |
| overactive parathyroid gland | 0.335807 |
| Blood. The cancer | 0.269699 |
| blood | 0.359167 |
| cancer research process | 0.266446 |
| cancer clinical trials | 0.322533 |
| tumor | 0.275377 |
| cancer information summaries | 0.272885 |
| comprehensive cancer information | 0.272952 |
| parathyroid cancer signs | 0.373584 |
|
CLICK HERE |
| 1701 |
National Cancer Institute |
Html |
en |
Pathology Reports |
A fact sheet describing the information found in a pathology report, the document that contains results of the examination of tissue removed during biopsy or surgery. |
| NCI-designated cancer centers | 0.497751 |
| technical medical language | 0.492686 |
| pathology report | 0.906587 |
| certain noncancerous conditions | 0.486594 |
| pathology results | 0.507902 |
| tissue | 0.71912 |
| Pathology reports | 0.571018 |
| cancer cells | 0.487918 |
| malignant cells | 0.475383 |
| Cancer Information Service | 0.505692 |
| microscope | 0.502866 |
| ) sections. | 0.523472 |
| different cancer types | 0.498063 |
| frozen section | 0.50145 |
| naked eye | 0.506619 |
| permanent) sections. | 0.503784 |
| clinical trials | 0.546491 |
| flow cytometry | 0.487161 |
| tumor cells | 0.49749 |
| normal cells | 0.47705 |
| particular DNA sequence | 0.477991 |
| entire tumor | 0.507705 |
| tumor markers | 0.496268 |
|
| tissue culture | 0.501671 |
| tissue sample | 0.575447 |
| chronic myelogenous leukemia | 0.479887 |
| diagnosis | 0.476227 |
| normal tissue | 0.5122 |
| pathology laboratory | 0.521862 |
| tissue samples | 0.511673 |
| frozen sections | 0.490304 |
| clinical trials page | 0.487126 |
| particular DNA sequences | 0.478454 |
| Polymerase chain reaction | 0.483064 |
| Western blot hybridization | 0.484206 |
| cells | 0.582619 |
| tissue firm | 0.512918 |
| biopsy date | 0.47785 |
| live cells | 0.477142 |
| gross description | 0.504759 |
| biopsy | 0.507407 |
| particularly genetic alterations | 0.48591 |
| information | 0.537969 |
| cancer | 0.518713 |
| pathologist | 0.518021 |
| pathology specimens | 0.507289 |
|
CLICK HERE |
| 1720 |
National Cancer Institute |
Html |
en |
Vitamin D and Cancer Prevention |
A fact sheet that summarizes the results of studies on vitamin D and cancer prevention. It includes information about dietary recommendations for vitamin D. |
| Vitamin D2 | 0.702012 |
| vitamin D intake | 0.693686 |
| vitamin D toxicity | 0.68752 |
| vitamin D analogs | 0.666953 |
| Vitamin D. IARC | 0.695151 |
| true vitamin | 0.68097 |
| cancer cell growth | 0.487686 |
| vitamin D. Cancer | 0.718314 |
| colorectal cancer risk | 0.525733 |
| vitamin D receptor | 0.666091 |
| blood levels | 0.512913 |
| Dietary Reference Intakes | 0.609551 |
| Vitamin D. Vitamin | 0.928771 |
| high vitamin | 0.694198 |
| additional vitamin | 0.676051 |
| body use calcium | 0.477006 |
| reduced risk | 0.467625 |
| vitamin D supplements | 0.744471 |
| colorectal cancer | 0.645145 |
| Review Dietary Reference | 0.469981 |
| IARC Working Group | 0.527229 |
| National Academies Press | 0.491383 |
| higher blood levels | 0.477109 |
| adequate vitamin | 0.691809 |
| vitamin | 0.965047 |
|
| clinical cancer research | 0.487804 |
| vitamin D levels | 0.742304 |
| calcium levels | 0.481333 |
| Vitamin D deficiency | 0.717219 |
| Cancer Epidemiology | 0.476212 |
| pre-diagnostic circulating vitamin | 0.676944 |
| vitamin D. Excessive | 0.718069 |
| Vitamin D/Calcium Polyp | 0.693854 |
| Muñoz A. Vitamin | 0.683479 |
| dietary vitamin | 0.716868 |
| dietary supplements | 0.510452 |
| National Cancer Institute | 0.502108 |
| average dietary intakes | 0.505042 |
| lower cancer incidence | 0.486263 |
| high intakes | 0.478398 |
| sunlight exposure | 0.498415 |
| Vitamin D. Washington | 0.692063 |
| vitamin D status | 0.736439 |
| higher intakes | 0.472172 |
| prostate cancer | 0.477824 |
| vitamin D3 | 0.72244 |
| et al | 0.609442 |
| high blood levels | 0.479072 |
| vitamin D supplementation | 0.707317 |
|
CLICK HERE |
| 1778 |
National Cancer Institute |
Html |
es |
Delirium (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del delirium como una complicación del cáncer o su tratamiento. Se discuten los abordajes de los cuidados médicos de apoyo, así como farmacológicos para el manejo del delirium. |
| delirium rating | 0.635037 |
| Cancer Res Clin | 0.330668 |
| Breitbart W | 0.391378 |
| recognizing delirium | 0.408363 |
| Misdiagnosing delirium | 0.408657 |
| Sin embargo | 0.38098 |
| delirium among elderly | 0.415971 |
| Fainsinger RL | 0.329645 |
| Lipowski ZJ | 0.334677 |
| Gagnon B | 0.354723 |
| Predicting delirium | 0.41556 |
| risk factors | 0.327409 |
| Delirium Assessment Scale | 0.517982 |
| Delirium risk | 0.412345 |
| Delirium presenting with | 0.419293 |
| patients with delirium | 0.445355 |
| Natl Cancer Inst | 0.328774 |
| antipsicóticos tÃpicos | 0.342502 |
| McCallion J | 0.33665 |
| Lawlor PG | 0.511955 |
| término delirium | 0.437321 |
| Neuropsychiatry Clin Neurosci | 0.328992 |
| Mancini IL | 0.351836 |
| hospitalized patients with | 0.376004 |
| especÃfica cuáles pacientes | 0.32777 |
|
| Palliat Care | 0.338189 |
| patients with | 0.960984 |
| Pain Symptom Manage | 0.86069 |
| prevent delirium | 0.429024 |
| Miller L | 0.327272 |
| American Psychiatric Association | 0.3525 |
| bedside confusion scale | 0.336758 |
| Care Cancer | 0.332558 |
| palliative care | 0.358676 |
| hospitalized elderly | 0.35987 |
| Memorial Delirium Assessment | 0.513933 |
| Delirium after | 0.413891 |
| Intern Med | 0.666809 |
| delirium rating scale-revised-98 | 0.51332 |
| confusion assessment method | 0.339276 |
| Clin Oncol | 0.334335 |
| Arch Intern Med | 0.574627 |
| Bruera E | 0.37373 |
| with adjuvant | 0.332147 |
| elderly patient | 0.402747 |
| terminal delirium | 0.422735 |
| antipsicóticos atÃpicos | 0.439946 |
| prospective study | 0.581043 |
| Inouye SK | 0.47182 |
|
CLICK HERE |
| 1905 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de hígado infantil (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de hígado infantil. |
| grupo iii | 0.507215 |
| siguientes procedimientos | 0.435845 |
| grupo posttext | 0.428004 |
| efectos secundarios meses | 0.436827 |
| cuáles secciones | 0.430744 |
| pequeña cantidad | 0.417301 |
| grupos pretext | 0.622136 |
| grupo pretext | 0.494022 |
| rayos x | 0.426417 |
| niño ayuda | 0.426517 |
| grupo ii | 0.508034 |
| cuerpo usa | 0.472879 |
| ondas sonoras | 0.42867 |
| efectos tardÃos | 0.57237 |
| PDQ Efectos tardÃos | 0.457898 |
| National Cancer Institute | 0.41066 |
| IRMN).Ampliar Imágenes | 0.423392 |
|
| microesferas minúsculas | 0.417674 |
| Instituto Nacional | 0.442931 |
| PDQ Tratamiento | 0.80031 |
| determinados cambios | 0.489668 |
| caracterÃsticas histológicas | 0.903803 |
| nuevos tipos | 0.420467 |
| grupo iv | 0.455083 |
| distintos tipos | 0.457348 |
| Physician Data Query | 0.443332 |
| Estados Unidos | 0.431258 |
| siguientes situaciones | 0.427998 |
| abdomen.ampliar exploración | 0.426559 |
| siguientes enlaces | 0.410964 |
| altas concentraciones | 0.429265 |
| sanguÃneos principales.ampliar ecografÃa | 0.456159 |
| siguientes trastornos | 0.423684 |
|
CLICK HERE |
| 3459 |
National Cancer Institute |
Html |
es |
Coenzima Q10 (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos sobre el uso de la conzima Q10 como tratamiento para las personas con cáncer. |
| Centro Nacional | 0.333125 |
| Vitamina Q10 | 0.341732 |
| New Hampshire Avenue | 0.323053 |
| Drug Administration | 0.314317 |
| leucemia linfoblástica aguda | 0.341078 |
| NCI Best Case | 0.342133 |
| vÃa oral | 0.324149 |
| mejores pruebas | 0.318969 |
| datos bibliográficos pubmed | 0.324983 |
| siguientes preguntas | 0.314202 |
| mayores cantidades | 0.322901 |
| Premio Nobel | 0.323381 |
| siguientes riesgos | 0.318032 |
| máximo nivel | 0.322444 |
| seguro médico | 0.313926 |
| Instituto Nacional | 0.428917 |
| vitamina e | 0.322593 |
| conzima q10 | 0.331342 |
| Salud Complementaria | 0.35167 |
|
| Visuals Online | 0.317138 |
| complementarias revisa | 0.324022 |
| daños causados​por | 0.322061 |
| Physician Data Query | 0.399292 |
| coenzima q10 | 0.631002 |
| Estados Unidos | 0.532938 |
| cáncer doxorrubicina | 0.420236 |
| antraciclina doxorrubicina | 0.326213 |
| libre uso | 0.31803 |
| página manejo | 0.315983 |
| ¿El tratamiento | 0.336183 |
| ¿Los beneficios | 0.314951 |
| CoQ10 ayuda | 0.788819 |
| cuerpo elabora | 0.394571 |
| coenzima ayuda | 0.33485 |
| Series Program | 0.314402 |
| medicina complementaria | 0.970585 |
| siguientes deficiencias | 0.324091 |
|
CLICK HERE |
| 3566 |
National Cancer Institute |
Html |
en |
Training |
NCI offers training at laboratories and clinics in Maryland and at universities and institutions nationwide. These cancer training and career development opportunities cover a broad spectrum of disciplines for individuals at career stages ranging from high school and graduate students to scientists, clinicians, and health care professionals. |
| National Cancer Institute | 0.966549 |
|
|
CLICK HERE |
| 3856 |
National Cancer Institute |
Html |
en |
Christal Sohl, Ph.D. |
The San Diego State University biologist uses a variety of methods, including structural, computational, and kinetic analyses, to study enzymes that may play a role in cancer. |
| personal time | 0.583145 |
| polymerase enzymes | 0.576932 |
| isocitrate dehydrogenase | 0.57565 |
| environmental pollutants | 0.576985 |
| Fred Guengerich | 0.587519 |
| cell growth | 0.572096 |
| K99/R00 grant application | 0.63899 |
| job applications | 0.56948 |
| generous people | 0.568794 |
| enzyme structure | 0.620541 |
| mutated conditions | 0.575037 |
| cancer-promoting metabolite | 0.574359 |
| Diego State University | 0.633881 |
| graduate school | 0.57248 |
| single point mutation | 0.637959 |
| research career | 0.583765 |
| strong mentoring relationships | 0.632479 |
| biological substrate | 0.582981 |
| daunting prospect | 0.569185 |
| enzyme functions | 0.618027 |
| Dr. Guengerich | 0.599167 |
| tumor-suppressing effects | 0.571078 |
| brand-new assistant professor | 0.63038 |
| clinically relevant problem | 0.636226 |
| research goal | 0.576225 |
|
| SDSU students | 0.573824 |
| postdoc Dr | 0.580928 |
| kinases—cellular signaling proteins | 0.631824 |
| Vanderbilt University | 0.576153 |
| cancer drugs | 0.568875 |
| R01 grant | 0.59259 |
| human disease | 0.573514 |
| K99/R00 grant | 0.703102 |
| George Richter-Addo | 0.576773 |
| undergraduate biochemistry course | 0.648526 |
| Yale University | 0.573003 |
| enzyme kinetics—the study | 0.706771 |
| earlier career stages | 0.620329 |
| enzymatic reaction | 0.574931 |
| inaccurate DNA replication | 0.627233 |
| assistant professor | 0.762524 |
| Karen Anderson | 0.570977 |
| K99/R00 transition grant | 0.643727 |
| Dr. Sohl | 0.961111 |
| hard work | 0.580209 |
| enzyme kinetics—and | 0.636377 |
| single step | 0.57426 |
| DNA strands | 0.56849 |
| Christal Sohl | 0.703616 |
|
CLICK HERE |
| 15646 |
National Cancer Institute |
Html |
en |
Grants Management Contacts |
null |
| LIPSCOMB UNIVERSITY UTTER | 0.614715 |
| UNIVERSITY HEALTH SCIENCES | 0.625816 |
| MEDICAL CENTER WALTERS | 0.616396 |
| STATE UNIVERSITY PRITCHARD | 0.643659 |
| HOWARD UNIVERSITY KEARSE | 0.605096 |
| STATE UNIVERSITY COFIE | 0.614592 |
| MEDICAL CENTER | 0.875732 |
| BROWN UNIVERSITY KEARSE | 0.615759 |
| CAROLINA STATE UNIVERSITY | 0.619853 |
| STATE UNIVERSITY SALO | 0.669411 |
| STATE UNIVERSITY KNOWLES | 0.615594 |
| STATE UNIVERSITY KEARSE | 0.653523 |
| UNIVERSITY HEALTH | 0.637053 |
| STATE UNIVERSITY MONTES | 0.717388 |
| AMERICAN UNIVERSITY SOWELL | 0.638565 |
| ATLANTIC UNIVERSITY KEARSE | 0.609604 |
| STATE UNIVERSITY MEININGER | 0.613395 |
| RESEARCH INSTITUTE | 0.777493 |
| ALABAMA STATE UNIVERSITY | 0.62296 |
| BAYLOR UNIVERSITY PRITCHARD | 0.613283 |
| UNIVERSITY CHICAGO NGUYEN | 0.608201 |
| STATE UNIVERSITY HICKMAN | 0.625736 |
| MCGILL UNIVERSITY UTTER | 0.611917 |
| STATE UNIVERSITY MITCHELL | 0.672133 |
| STATE UNIVERSITY NGUYEN | 0.639382 |
|
| RESERVE UNIVERSITY KEARSE | 0.613085 |
| cancer research | 0.608564 |
| UNIVERSITY MEDICAL CAMPUS | 0.61532 |
| CHICAGO STATE UNIVERSITY | 0.608015 |
| DUQUESNE UNIVERSITY WALTERS | 0.608895 |
| STATE UNIVERSITY | 0.98856 |
| STATE UNIVERSITY WONG | 0.676901 |
| LINDA UNIVERSITY UTTER | 0.613669 |
| MEDICAL CENTER MONTES | 0.63558 |
| MEDICAL UNIVERSITY SOWELL | 0.63184 |
| UNIVERSITY HEALTH CTR | 0.621136 |
| ARIZONA UNIVERSITY MONTES | 0.636738 |
| CALIFORNIA STATE UNIVERSITY | 0.645138 |
| UNIVERSITY WALTERS | 0.616172 |
| UNIVERSITY KEARSE | 0.654785 |
| RESEARCH INSTITUTE MONTES | 0.613304 |
| AMERICAN UNIVERSITY MONTES | 0.657637 |
| STATE UNIVERSITY SACRAMENTO | 0.604248 |
| STATE UNIVERSITY REIS | 0.609221 |
| CLARKSON UNIVERSITY MONTES | 0.653016 |
| FLORIDA STATE UNIVERSITY | 0.608756 |
| STATE UNIVERSITY UTTER | 0.65066 |
| STATE UNIVERSITY BAILEY | 0.715208 |
| UNIVERSITY MEDICAL CENTER | 0.735227 |
|
CLICK HERE |